EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pustular psoriasis: A distinct aetiopathogenic and clinical entity

Biju Vasudevan, Pankaj Das, Siddharth Bhatt

Indian Journal of Dermatology, Venereology and Leprology · 28.05.2023 · 90 · 19-29

DOI: 10.25259/ijdvl_542_2022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, online erschienen am 28.05.2023. Verfasst von Biju Vasudevan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Armed Forces Medical College (AFMC), Wanowarie, Pune, India. Hauptthemen laut MEDLINE: Psoriasis, Biological Products. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pustular psoriasis is a distinct subset of psoriasis that presents with involvement of the skin in the form of sterile pustules along with systemic manifestations. Though it has been conventionally grouped under the umbrella of psoriasis, recent research has shed light on its pathogenetic mechanisms associated with the IL-36 pathway, which is distinct from conventional psoriasis. Pustular psoriasis in itself is a heterogeneous entity consisting of various subtypes, including generalised, localised, acute, and chronic forms. There is confusion regarding its current classification as entities like deficiency of IL-36 antagonist (DITRA) which are closely related to pustular psoriasis both in their pathogenetic mechanism and its clinical manifestations, are not included under pustular psoriasis. Entities like palmoplantar pustulosis, which presents with similar clinical features but is pathogenetically distinct from other forms of pustular psoriasis, are included under this condition. Management of pustular psoriasis depends upon its severity; while some of the localised variants can be managed with topical therapy alone, the generalised variants like Von Zumbusch disease and impetigo herpetiformis may need intensive care unit admission and tailor-made treatment protocols. The advent of newer biologics and better insight into the pathogenesis of pustular psoriasis has opened the way for newer therapies, including tumour necrosis factor-alpha inhibitors, interleukin-1 inhibitors, interleukin-17 inhibitors, and granulocyte monocyte apheresis. It continues to be an enigma whether pustular psoriasis is actually a variant of psoriasis or an entirely different disease entity, though we feel that it is an entirely different disease process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisBiological ProductsHumansSkinInterleukins

Stichwörter der Autor:innen

Generalized pustular psoriasisacrodermatitis continua of Hallopeauimpetigo herpetiformisinfantile pustular psoriasispustular psoriasis in childhood

Substanzen

InterleukinsBiological Products

Autor:innen und Institutionen

  • Department of Dermatology, Armed Forces Medical College (AFMC), Wanowarie, Pune, India.

Zitieren

APA

Vasudevan, B., Das, P., & Bhatt, S. (2023). Pustular psoriasis: A distinct aetiopathogenic and clinical entity. Indian Journal of Dermatology, Venereology and Leprology, 90, 19-29. https://doi.org/10.25259/ijdvl_542_2022

Vancouver

Vasudevan B, Das P, Bhatt S. Pustular psoriasis: A distinct aetiopathogenic and clinical entity. Indian Journal of Dermatology, Venereology and Leprology. 2023;90:19-29. doi:10.25259/ijdvl_542_2022

BibTeX
@article{Vasudevan2023,
  author = {Vasudevan, Biju and Das, Pankaj and Bhatt, Siddharth},
  title = {Pustular psoriasis: A distinct aetiopathogenic and clinical entity},
  journal = {Indian Journal of Dermatology, Venereology and Leprology},
  year = {2023},
  volume = {90},
  pages = {19--29},
  doi = {10.25259/ijdvl_542_2022}
}
Kostenlos starten →